Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...
Having a higher level of cardiorespiratory fitness reduced the risk for cognitive decline and Alzheimer’s, even in people at ...
The ordinance faced weeks of steady opposition from Councilmember Eric Guerra and public health organizations.
The American Lung Association released its annual “State of Lung Cancer” report that ranks lung cancer response by state.
Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...
The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
Existing research has tied sedentary behavior to a slew of health problems in both children and adults, from obesity and poor ...
"AHA 2024: Zerlasiran shows promising Phase II results for elevated lipoprotein (a)" was originally created and published by ...
Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial ...
Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...
Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.